Michael Evans, RPh, director, ambulatory clinical pharmacy programs, says that medication therapy management (MTM) programs present various challenges. In particular, those challenges include medication reconciliation, ensuring that patients are adherent to their medications, and clinician prescribing practices.
Michael Evans, RPh, director, ambulatory clinical pharmacy programs, Geisinger Health System, says that medication therapy management (MTM) programs present various challenges. In particular, those challenges include medication reconciliation, ensuring that patients are adherent to their medications, and clinician prescribing practices. Dr Evans explains that with biologics and other high-cost prescription medications, clinicians often incorrectly assume that a patient will adhere simply because they are in need of a certain drug. However, the likelihood is no different from any other chronic illness, in which the patient is adherent only 50% — or less – of the time.
“As we’ve interviewed and we’ve spent time with clinicians, they’re writing their prescriptions for the biologic, for the patient, and that’s where their therapy or their follow up for the patient typically ends,” Dr Evans says. “They assume since they’re writing the prescription, it’s a high dollar, high risk, the patient really needs it, they assume the patient’s adherent to the therapy.”
Dr Evans says that by involving pharmacists in a therapy regimen, the organization was able to take patients off medications they were not benefitting from and find other prescriptions that would produce the same outcome but at a lower cost. He says, “It’s a small number, a small percentage of patients, but it’s a large percent of our spend in the ACO so that’s why we’re targeting that population.”
He adds that keeping electronic health records up-to-date and providing the right medications to the right patients are additional challenges in medication management.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More